{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T15:09:30Z","timestamp":1769267370233,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T00:00:00Z","timestamp":1536969600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13000-018-0749-1","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T01:59:53Z","timestamp":1537063193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2\/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma"],"prefix":"10.1186","volume":"13","author":[{"given":"Lemeng","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangshu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuwei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,15]]},"reference":[{"key":"749_CR1","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.2741\/3736","volume":"16","author":"A Escudero-Esparza","year":"2010","unstructured":"Escudero-Esparza A, Jiang WG, Martin TA. The Claudin family and its role in cancer and metastasis. Front Biosci (Landmark ed). 2010;16:1069\u201383.","journal-title":"Front Biosci (Landmark ed)"},{"key":"749_CR2","first-page":"2851","volume":"34","author":"C Cunniffe","year":"2014","unstructured":"Cunniffe C, Brankin B, Lambkin H, Ryan F. The role of Claudin-1 and Claudin-7 in cervical tumorigenesis. Anticancer Res. 2014;34:2851\u20137.","journal-title":"Anticancer Res"},{"key":"749_CR3","first-page":"73","volume":"2011","author":"K Turksen","year":"1816","unstructured":"Turksen K, Troy TC. Junctions gone bad: claudins and loss of the barrier in cancer. Biochim Biophys Acta. 1816;2011:73\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"749_CR4","doi-asserted-by":"publisher","unstructured":"Ouban A. Claudin-1 role in colon cancer: an update and a review. Histol Histopathol. 2018;11980. https:\/\/doi.org\/10.14670\/HH-11-980 .","DOI":"10.14670\/HH-11-980"},{"key":"749_CR5","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1074\/mcp.M117.068577","volume":"16","author":"TS Worst","year":"2017","unstructured":"Worst TS, von Hardenberg J, Gross JC, Erben P, Schnolzer M, Hausser I, Bugert P, Michel MS, Boutros M. Database-augmented mass spectrometry analysis of exosomes identifies Claudin 3 as a putative prostate Cancer biomarker. Mol Cell Proteomics. 2017;16:998\u20131008.","journal-title":"Mol Cell Proteomics"},{"key":"749_CR6","first-page":"209","volume":"56","author":"MA Szasz","year":"2012","unstructured":"Szasz MA. Claudins as prognostic factors of breast cancer. Magy Onkol. 2012;56:209\u201312.","journal-title":"Magy Onkol"},{"key":"749_CR7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/PGP.0000000000000394","volume":"37","author":"L Martin de la Fuente","year":"2018","unstructured":"Martin de la Fuente L, Malander S, Hartman L, Jonsson JM, Ebbesson A, Nilbert M, Masback A, Hedenfalk I. Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response. Int J Gynecol Pathol. 2018;37:101\u20139.","journal-title":"Int J Gynecol Pathol"},{"key":"749_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bbamem.2007.08.018","volume":"1778","author":"L Gonz\u00e1lez-Mariscal","year":"2008","unstructured":"Gonz\u00e1lez-Mariscal L, Tapia R, Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta Biomembr. 2008;1778:729\u201356.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"749_CR9","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/S0955-0674(99)00016-2","volume":"11","author":"S Tsukita","year":"1999","unstructured":"Tsukita S, Furuse M, Itoh M. Structural and signalling molecules come together at tight junctions. Curr Opin Cell Biol. 1999;11:628\u201333.","journal-title":"Curr Opin Cell Biol"},{"key":"749_CR10","doi-asserted-by":"publisher","first-page":"6592","DOI":"10.1038\/onc.2017.259","volume":"36","author":"R Ahmad","year":"2017","unstructured":"Ahmad R, Kumar B, Chen Z, Chen X, Muller D, Lele SM, Washington MK, Batra SK, Dhawan P, Singh AB. Loss of claudin-3 expression induces IL6\/gp130\/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt\/beta-catenin signaling. Oncogene. 2017;36:6592\u2013604.","journal-title":"Oncogene"},{"key":"749_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2017.05.033","volume":"403","author":"K Takasawa","year":"2017","unstructured":"Takasawa K, Takasawa A, Osanai M, Aoyama T, Ono Y, Kono T, Hirohashi Y, Murata M, Sawada N. Claudin-18 coupled with EGFR\/ERK signaling contributes to the malignant potentials of bile duct cancer. Cancer Lett. 2017;403:66\u201373.","journal-title":"Cancer Lett"},{"key":"749_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"749_CR13","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.18632\/oncotarget.2288","volume":"5","author":"L Jiang","year":"2014","unstructured":"Jiang L, Yang YD, Fu L, Xu W, Liu D, Liang Q, Zhang X, Xu L, Guan XY, Wu B, et al. CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma. Oncotarget. 2014;5:7663\u201376.","journal-title":"Oncotarget"},{"key":"749_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/1746-1596-8-205","volume":"8","author":"M Gao","year":"2013","unstructured":"Gao M, Li W, Wang H, Wang G. The distinct expression patterns of claudin-10, \u221214, \u221217 and E-cadherin between adjacent non-neoplastic tissues and gastric cancer tissues. Diagn Pathol. 2013;8:205.","journal-title":"Diagn Pathol"},{"key":"749_CR15","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1038\/onc.2012.505","volume":"32","author":"Y Suh","year":"2013","unstructured":"Suh Y, Yoon CH, Kim RK, Lim EJ, Oh YS, Hwang SG, An S, Yoon G, Gye MC, Yi JM, et al. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells. Oncogene. 2013;32:4873\u201382.","journal-title":"Oncogene"},{"key":"749_CR16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/onc.2016.294","volume":"36","author":"Y Suh","year":"2017","unstructured":"Suh Y, Yoon CH, Kim RK, Lim EJ, Oh YS, Hwang SG, An S, Yoon G, Gye MC, Yi JM, et al. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells. Oncogene. 2017;36:1167\u20138.","journal-title":"Oncogene"},{"key":"749_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/carcin\/bgw036","volume":"37","author":"CP Li","year":"2016","unstructured":"Li CP, Cai MY, Jiang LJ, Mai SJ, Chen JW, Wang FW, Liao YJ, Chen WH, Jin XH, Pei XQ, et al. CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma. Carcinogenesis. 2016;37:557\u201366.","journal-title":"Carcinogenesis"},{"key":"749_CR18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev-physiol-030212-183809","volume":"75","author":"M Koval","year":"2013","unstructured":"Koval M. Claudin heterogeneity and control of lung tight junctions. Annu Rev Physiol. 2013;75:551\u201367.","journal-title":"Annu Rev Physiol"},{"key":"749_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13046-017-0558-5","volume":"36","author":"S Cherradi","year":"2017","unstructured":"Cherradi S, Ayrolles-Torro A, Vezzo-Vie N, Gueguinou N, Denis V, Combes E, Boissiere F, Busson M, Canterel-Thouennon L, Mollevi C, et al. Antibody targeting of claudin-1 as a potential colorectal cancer therapy. J Exp Clin Cancer Res. 2017;36:89.","journal-title":"J Exp Clin Cancer Res"},{"key":"749_CR20","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.18632\/oncotarget.2858","volume":"6","author":"R Philip","year":"2015","unstructured":"Philip R, Heiler S, Mu W, Buchler MW, Zoller M, Thuma F. Claudin-7 promotes the epithelial-mesenchymal transition in human colorectal cancer. Oncotarget. 2015;6:2046\u201363.","journal-title":"Oncotarget"},{"key":"749_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022119","volume":"6","author":"N Dahiya","year":"2011","unstructured":"Dahiya N, Becker KG, Wood WH 3rd, Zhang Y, Morin PJ. Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion. PLoS One. 2011;6:e22119.","journal-title":"PLoS One"},{"issue":"1","key":"749_CR22","first-page":"83","volume":"25","author":"A Ouban","year":"2010","unstructured":"Ouban A, Ahmed A. Claudins in human cancer, a review. Histol Histopathol. 2010;25(1):83\u201390.","journal-title":"Histol Histopathol"},{"key":"749_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/07357907.2010.512594","volume":"29","author":"VE Zavala-Zendejas","year":"2011","unstructured":"Zavala-Zendejas VE, Torres-Martinez AC, Salas-Morales B, Fortoul TI, Montano LF, Rendon-Huerta EP. Claudin-6, 7, or 9 overexpression in the human gastric adenocarcinoma cell line AGS increases its invasiveness, migration, and proliferation rate. Cancer Investig. 2011;29:1\u201311.","journal-title":"Cancer Investig"},{"key":"749_CR24","first-page":"2517","volume":"31","author":"T Yoshida","year":"2011","unstructured":"Yoshida T, Kinugasa T, Akagi Y, Kawahara A, Romeo K, Shiratsuchi I, Ryu Y, Gotanda Y, Shirouzu K. Decreased expression of claudin-1 in rectal cancer: a factor for recurrence and poor prognosis. Anticancer Res. 2011;31:2517\u201325.","journal-title":"Anticancer Res"},{"key":"749_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12032-015-0600-4","volume":"32","author":"X Zhang","year":"2015","unstructured":"Zhang X, Ruan Y, Li Y, Lin D, Quan C. Tight junction protein claudin-6 inhibits growth and induces the apoptosis of cervical carcinoma cells in vitro and in vivo. Med Oncol. 2015;32:148.","journal-title":"Med Oncol"},{"key":"749_CR26","volume-title":"Functions of claudin-7 in human lung cancer","author":"Z Lu","year":"2012","unstructured":"Lu Z: Functions of claudin-7 in human lung cancer. 2012."},{"key":"749_CR27","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1002\/ijc.28857","volume":"135","author":"P Micke","year":"2014","unstructured":"Micke P, Mattsson JS, Edlund K, Lohr M, Jirstrom K, Berglund A, Botling J, Rahnenfuehrer J, Marincevic M, Ponten F, et al. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer. Int J Cancer. 2014;135:2206\u201314.","journal-title":"Int J Cancer"},{"key":"749_CR28","doi-asserted-by":"publisher","first-page":"26233","DOI":"10.1074\/jbc.M502003200","volume":"280","author":"T D'Souza","year":"2005","unstructured":"D'Souza T, Agarwal R, Morin PJ. Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. J Biol Chem. 2005;280:26233\u201340.","journal-title":"J Biol Chem"},{"key":"749_CR29","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1016\/j.yexcr.2007.06.026","volume":"313","author":"T D'Souza","year":"2007","unstructured":"D'Souza T, Indig FE, Morin PJ. Phosphorylation of claudin-4 by PKC\u03b5 regulates tight junction barrier function in ovarian cancer cells. Exp Cell Res. 2007;313:3364\u201375.","journal-title":"Exp Cell Res"},{"key":"749_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3892\/ol.2013.1330","volume":"6","author":"X Li","year":"2013","unstructured":"Li X, Li Y, Qiu H, Wang Y. Downregulation of claudin-7 potentiates cellular proliferation and invasion in endometrial cancer. Oncol Lett. 2013;6:101\u20135.","journal-title":"Oncol Lett"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-018-0749-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13000-018-0749-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-018-0749-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T22:59:43Z","timestamp":1604962783000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-018-0749-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,15]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1186\/s13000-018-0749-1","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,15]]},"assertion":[{"value":"25 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Jilin University (reference number 20070459). Written informed consent was obtained from all patients at the time of their treatment for the use of material in future research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"72"}}